Tag Archives: public policy

The Hill: Innovation-focused tax reform for U.S. global competitiveness

DC in Fall

The Hill Blog published an op-ed by Geoff Davis on ‘Innovation-focused tax reform for U.S. global competitiveness.’ Davis, a former member of the House Ways & Means Committee, which has responsibility for writing our nation’s tax laws,  urges policymakers to support innovative, research-intensive businesses by encouraging private investment as they move towards tax reform. As he states, “If the U.S. is to remain competitive in the global economy, we need to make sure there are policies Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Unraveling the Mystery of Alzheimer’s Disease

drew-headshot

Preeminent researchers from around the world gathered recently to tackle the science behind one of medicine’s toughest problems – Alzheimer’s – and elevating the disease as a top global priority. The Global CEO Initiative on Alzheimer’s Disease (CEOi) – a coalition of corporations from the fields of biotechnology, pharmaceuticals, diagnostics, finance, and healthcare – hosted a dinner during the Alzheimer’s Association International Convention (AAIC) in Boston. The CEOi had already taken strides to achieve this Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Pivotal Role the Public Market Plays in Financing R&D

KennethMoch-Chimerix

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle – the daily challenge of running a growing company combined with the roadblocks intrinsic to groundbreaking scientific advancement. Innovative companies must overcome capital formation barriers in order to fund their next generation R&D.  The financing challenges that emerging biotechs face are unique, but we have the potential to save lives and treat patients in desperate need of hope. Today, I Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Nationwide Track and Trace System is Urgently Needed

Jim Greenwood

Today’s pharmaceutical distribution supply chain is governed largely by a patchwork of state laws and regulations that allows criminals to enter markets with the lowest safety requirements to inject counterfeit, unsafe, and potentially lethal products into the national supply chain. The state-by-state system is both onerous and ineffective, and the risk it poses to public health from counterfeiters can no longer be ignored. In a recent opinion piece for Roll Call, I write that: “Congress Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Congress Acts to Protect Public Health this Flu Season

Chris

The next flu season may be months away, but Congress already acted to ensure our nation is ready. Reps. Jim Gerlach (R-PA) and Richard Neal (D-MA), as well as Sens.  Max Baucus (D- MT) and Orrin Hatch (R-UT) introduced legislation which was recently enacted into law (H.R. 475) to update the National Vaccine Injury Compensation Program (VICP) to cover the newest flu vaccines in time for flu season, ensuring patient access to the latest therapies. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,